{"brief_title": "The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure", "brief_summary": "The purpose of this study is to determine if eplerenone is effective in the treatment of mild to moderate heart failure", "condition": "Heart Failure, Congestive", "intervention_type": "Drug", "intervention_name": "Eplerenone", "criteria": "Inclusion Criteria: - Current symptoms consistent with mild to moderate heart failure (NYHA functional class II and III) - LVEF (left ventricular ejection fraction) of <35% by equilibrium-gated RVG at screening - Therapy with an angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) and beta-blocker (BB) (unless documented intolerance) for at least 3 months duration and at dose that has not been adjusted within the previous 4 weeks Exclusion Criteria: - Current decompensated heart failure or heart failure hospitalization or severe heart failure (NYHA functional class IV) within 6 months of screening - Use of eplerenone or spironolactone within 30 days of randomization or for more than 7 days within the previous 6 months", "gender": "All", "minimum_age": "21 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00082589.xml"}